Report a Safety Concern
Search

The U.S. Nuclear Regulatory Commission is in the process of rescinding or revising guidance and policies posted on this webpage in accordance with Executive Order 14151 Ending Radical and Wasteful Government DEI Programs and Preferencing, and Executive Order 14168 Defending Women From Gender Ideology Extremism and Restoring Biological Truth to the Federal Government. In the interim, any previously issued diversity, equity, inclusion, or gender-related guidance on this webpage should be considered rescinded that is inconsistent with these Executive Orders.

Home NRC Library Basic References Glossary

Brachytherapy

A medical procedure during which a sealed radioactive source (or sources) is implanted directly into a person being treated for cancer (usually of the mouth, breast, lung, prostate, ovaries, or uterus). The radioactive implant may be temporary or permanent, and the radiation kills cells in the tumor as long as the device remains in place and emits radiation. Brachytherapy uses radioisotopes, such as iridium-192 or iodine-125, which are regulated by the NRC and Agreement States.

Page Last Reviewed/Updated Wednesday, February 15, 2023